Found: 13
Select item for more details and to access through your institution.
Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad315
- By:
- Publication type:
- Article
2744. A Phase I Randomized, Observer-Blind, Controlled, Dose Escalation Trial of the Safety and Tolerability of a Single Intramuscular Dose of a PAL Adjuvant (Laboratory Code, FB-631) Co-administered with Seasonal TIV (2013–2014) to Healthy Adults ≥18–50 Years of Age
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S966, doi. 10.1093/ofid/ofz360.2421
- By:
- Publication type:
- Article
2715. Pneumococcal Community-Acquired Pneumonia Attributed to PCV13 Serotypes in Hospitalized Adults: Comparison of the 50–64 and 65+ Age Groups.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S955, doi. 10.1093/ofid/ofz360.2392
- By:
- Publication type:
- Article
2714. Streptococcus pneumoniae Nasopharyngeal Carriage in Canadian Adults Hospitalized with Community-Acquired Pneumonia from 2010 to 2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S954, doi. 10.1093/ofid/ofz360.2391
- By:
- Publication type:
- Article
Clinical features and outcomes of influenza and RSV coinfections: a report from Canadian immunization research network serious outcomes surveillance network.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09033-5
- By:
- Publication type:
- Article
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 393, doi. 10.3390/vaccines8030393
- By:
- Publication type:
- Article
Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67931-9
- By:
- Publication type:
- Article
Older Age and Frailty are Associated with Higher Mortality but Lower ICU Admission with COVID-19.
- Published in:
- Canadian Geriatrics Journal, 2022, v. 25, n. 2, p. 183, doi. 10.5770/cgj.25.546
- By:
- Publication type:
- Article
A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 7, p. 1063, doi. 10.1093/cid/ciy244
- By:
- Publication type:
- Article
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network.
- Published in:
- Influenza & Other Respiratory Viruses, 2018, v. 12, n. 2, p. 232, doi. 10.1111/irv.12521
- By:
- Publication type:
- Article
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article